Tryptophan Missense Mutation in the Ligand‐Binding Domain of the Vitamin D Receptor Causes Severe Resistance to 1,25‐Dihydroxyvitamin D
Open Access
- 1 September 2002
- journal article
- case report
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 17 (9) , 1728-1737
- https://doi.org/10.1359/jbmr.2002.17.9.1728
Abstract
In this study, two related young children, brother and sister, exhibited severe vitamin D‐resistant rickets without alopecia. Sequence analysis of the total vitamin D receptor (VDR) cDNA from skin fibroblasts revealed a substitution of the unique tryptophan of the VDR by arginine at amino acid 286 (W286R). Cultured skin fibroblasts of the two patients expressed normal‐size VDR protein (immunocytochemistry and Western blotting) and normal length VDR mRNA (Northern blotting). But, these fibroblasts, as well as COS‐7 cells transfected with the W286R mutant, failed to bind 3H 1,25‐dihydroxyvitamin D3 [1,25(OH)2D3]. The tryptophan substitution did not affect VDR trafficking toward the nucleus but abolished the 24‐hydroxylase gene response to 1,25(OH)2D3, even at 10−6 M concentrations. In conclusion, this case report of a new family with hereditary vitamin D‐ resistant rickets (HVDRR) emphasizes the crucial role of the VDR tryptophan for ligand binding and for transactivation of 1,25(OH)2D3 target genes. It clearly shows the clinical significance of this VDR amino acid for calcium homeostasis and bone mineralization. This observation suggests further that the presence of a stable VDR‐bound ligand may not be obligatory for normal hair follicle development.Keywords
This publication has 39 references indexed in Scilit:
- The Unique Tryptophan Residue of the Vitamin D Receptor Is Critical for Ligand Binding and Transcriptional ActivationJournal of Bone and Mineral Research, 2001
- Molecular Modeling, Affinity Labeling, and Site-Directed Mutagenesis Define the Key Points of Interaction between the Ligand-Binding Domain of the Vitamin D Nuclear Receptor and 1α,25-Dihydroxyvitamin D3Biochemistry, 2000
- The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties RevealedJournal of Bone and Mineral Research, 1998
- Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.Journal of Clinical Investigation, 1997
- Transcriptional activation and dimerization functions in the human vitamin D receptorMolecular Endocrinology, 1996
- A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant ricketsJournal of Clinical Endocrinology & Metabolism, 1996
- Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3.Journal of Clinical Investigation, 1993
- The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families.Journal of Clinical Investigation, 1990
- Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D.Journal of Clinical Investigation, 1986
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970